Squarepoint’s Avita Medical RCEL Stock Holding History

Squarepoint’s Portfolio RCEL Stock Details RCEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$95K	Buy	+23,011	New	+$99.3K	﹤0.01%	4211
2024 Q3	–	Sell	-14,452	Closed	-$114K	–	4593
2024 Q2	$114K	Buy	+14,452	New	+$137K	﹤0.01%	3771
2023 Q4	–	Sell	-18,683	Closed	-$273K	–	4399
2023 Q3	$273K	Buy	+18,683	New	+$316K	﹤0.01%	3235
2023 Q2	–	Sell	-16,073	Closed	-$225K	–	3927
2023 Q1	$225K	Buy	16,073 +6,056	+60%	+$64.4K	﹤0.01%	2734
2022 Q4	$66.1K	Buy	+10,017	New	+$60K	﹤0.01%	3019
2022 Q3	–	Sell	-13,279	Closed	-$63K	–	3353
2022 Q2	$63K	Buy	+13,279	New	+$82K	﹤0.01%	2686

Other funds holding RCEL

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Squarepoint's RCEL Position: Q2 2026 in Review

Squarepoint opened a new position in Avita Medical (RCEL) in Q2 2026: 23,011 shares worth $95K. The stake represents ﹤0.01% of the portfolio and ranks #4211 among its holdings. This is a return to the name: Squarepoint previously reported a position in RCEL as recently as Q2 2024.

Squarepoint first reported a position in RCEL in Q2 2022 and has held it in 6 quarters since. The position peaked at $273K in Q3 2023. 73 funds tracked by Wall St. Rank hold RCEL as of Q2 2026.

Squarepoint held 23,011 shares of Avita Medical worth $95K as of Q2 2026.
Avita Medical was a new Squarepoint position in Q2 2026.
Avita Medical made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #4211 holding.
Squarepoint first reported a position in Avita Medical in Q2 2022 and has held it in 6 quarters since.
Squarepoint's Avita Medical position peaked at $273K in Q3 2023.
73 funds tracked by Wall St. Rank held Avita Medical as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.